Adial
Data Breaches, Cyber Attacks and Security Report
https://adialpharma.com ᛫
Last updated September 21, 2019
https://adialpharma.com ᛫
Last updated September 21, 2019
Adial Pharmaceuticals, Inc. ("the Company") is a clinical-stage biopharmaceutical company focused on the development of a therapeutic agent for the treatment of alcohol use disorder ("AUD") using its lead investigational new drug product, AD04, a selective serotonin-3 antagonist (i.e., a "5-HT3 antagonist").
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Adial is implementing good security practices.
{{ passedCheck.passTitle }}
{{ failedCheck.failTitle }}Read more about the latest issues in cybersecurity
Compare Adial's security performance with other companies